Skip to main content
. 2011 Jun 2;2:333–338. doi: 10.7150/jca.2.333

Figure 1.

Figure 1

- The putative immune-suppressive effects of Sorafenib are exerted on Dendritic Cells (DCs)/Antigen Presenting Cells (APCs) and Natural Killer (NK) cells.